Pharmacoeconomic analysis of epidermal growth factor (HeberprotP ®) for the treatment of diabetic foot ulcers
Introduction. The epidermal growth factor (EGF; HeberprotP ®) is the new treatment for deep persistent diabetic foot ulcers (Wagner grade 3–4). The effectiveness of EGF measured as the reduction of the time to complete granulation of tissue lesions was confirmed in randomised clinic...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Endocrinology Research Centre
2013-03-01
|
| Series: | Эндокринная хирургия |
| Subjects: | |
| Online Access: | https://surg-endojournals.ru/serg/article/viewFile/6366/4212 |